Microevolutionary analysis of Clostridium difficile genomes to investigate transmission

December 20, 2012 in Diseases, Conditions, Syndromes

Over recent years, hospital-acquired Clostridium difficile infections have been a significant problem in UK hospitals and globally. There have been concerns that infections may be due to transmission between symptomatic patients, either directly, or indirectly via hospital staff; these concerns were strengthened when enhanced infection control was introduced in England in 2007, and the incidence of C. difficile infection declined. A recent study published in the open access journal Genome Biology, published by BioMed Central, took a genomics approach to assess the incidence of patient-to-patient transmission of C. difficile. The study was supported by the National Institute of Heath Research Oxford Biomedical Research Centre – a collaboration between Oxford University Hospitals NHS Trust and Oxford University.

The team, led by Tim Peto and Rosalind Harding at the University of Oxford, sequenced the genomes of C. difficile isolated from 486 patients treated at four hospitals in Oxfordshire between 2006 and 2010. By counting the number of between different isolates and estimating the of the bacteria, the researchers were able to determine the likely time at which any two isolates became genetically separate and thus, whether the two patients in question could have plausibly caught the infection from each other in the hospital. In other words, implies a time-scale that can be used for judging the likelihood of direct transmission.

The results of the study indicated that, although transmission between patients is likely to occur, it actually happens at relatively low frequency. In particular, concerns that healthcare teams were spreading infection between different hospitals seem to be misplaced. One exception to this general finding is that there were a large number of cases of infection from one particular strain that does appear to have been due to patient-to-patient transmission, emphasising the epidemic nature of this lineage. Notably, this strain has declined in UK hospitals in the last five years.

Dr Xavier Didelot, the study's lead author, said: " This research opens up very exciting opportunities for better understanding how bacterial infections are spread, and what we can do to stop them. The reduced cost of sequencing whole bacterial genomes means we now have the technology for identifying very recent transmissions of infection. Moreover, we can apply this technology even in cases when infection control teams have no suspicion that routes of contact between patients might exist".

More information: Microevolutionary analysis of Clostridium difficile genomes to investigate transmission Xavier Didelot, David Eyre, Madeleine Cule, Camilla Ip, Azim Ansari, Dai Griffiths, Alison Vaughan, Lily O'Connor, Tanya Golubchik, Elizabeth Batty, Paolo Piazza, Daniel Wilson, Rory Bowden, Peter Donnelly, Kate Dingle, Mark Wilcox, Sarah Walker, Derrick Crook, Tim Peto and Rosalind Harding Genome Biology (in press)

Journal reference: Genome Biology search and more info website

Provided by BioMed Central search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Little evidence for prediction rules for low back pain

(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...

Diseases, Conditions, Syndromes created 12 hours ago | popularity not rated yet | comments 0 | with audio podcast

New malaria test kit gives a boost to elimination efforts worldwide

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...

Diseases, Conditions, Syndromes created 16 hours ago | popularity not rated yet | comments 0

WHO says single yellow fever shot is enough

(AP)—The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary.

Diseases, Conditions, Syndromes created 17 hours ago | popularity not rated yet | comments 0

23 dead in initiation rites in South Africa

(AP)—Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday.

Diseases, Conditions, Syndromes created 17 hours ago | popularity 5 / 5 (1) | comments 2

Expert questions US public health agency advice on influenza vaccines

The United States government public health agency, the CDC, pledges "To base all public health decisions on the highest quality scientific data, openly and objectively derived." But Peter Doshi, a postdoctoral fellow at Johns ...

Diseases, Conditions, Syndromes created May 16, 2013 | popularity not rated yet | comments 0


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...